Patent Assignment
Reel/Frame 074591/0816
Security Interest
Recorded: 2026-05-07
Received: 2026-05-07
Pages: 10
Assignor
SCIENTURE, LLC
Executed: 2026-04-27
Assignee
STREETERVILLE CAPITAL, LLC
297 AUTO MALL DRIVE, SUITE #4, ST. GEORGE, UT, 84770, UNITED STATES
Covered Properties
(14)
Losartan Liquid Formulations and Methods of Use
Application:
19/080,602 →
Losartan Liquid Formulations and Methods of Use
Application:
18/421,405 →
Losartan Liquid Formulations and Methods of Use
Application:
18/061,819 →
Losartan Liquid Formulations and Methods of Use
Application:
18/052,116 →
Long-Acting Bupivacaine Microsphere Formulations
Application:
17/996,995 →
Long-Acting Apomorphine Formulations and Injectors for Therapeutic Delivery of the Same
Application:
17/995,888 →
Dihydroergotamine Mesylate Formulations and Pre-Filled Injectors for Therapeutic Delivery of the Same
Application:
17/757,924 →
Losartan Liquid Formulations and Methods of Use
PCT:
PCTUS2021054054 ↗
Unified Graphical User Interface for Devices in a Wireless Network
Application:
17/312,566 →
Long-Acting Bupivacaine Microsphere Formulations
PCT:
PCTUS2021028718 ↗
Long-Acting Apomorphine Formulations and Injectors for Therapeutic Delivery of the Same
PCT:
PCTUS2021026904 ↗
Dihydroergotamine Mesylate Formulations and Pre-Filled Injectors for Therapeutic Delivery of the Same
PCT:
PCTUS2020066482 ↗
Losartan Liquid Formulations and Methods of Use
Application:
63/089,950 →
Long-Acting Bupivacaine Microsphere Formulations
Application:
63/013,736 →